QualityStocksNewsBreaks – INmune Bio, Inc.’s (NASDAQ: INMB) XPro1595 Highlighted During Press Conference at the Society for Neuroscience 49th Annual Meeting
INmune Bio (NASDAQ: INMB) on Monday announced that Malú Tansey, Ph.D., Professor of Neuroscience and Director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida College of Medicine, presented data that demonstrated the use of INmune Bio’s lead compound, XPro1595, to lessen the exacerbation of Alzheimer’s-like pathology brought on by a high fat and high fructose diet in mice. Dr. Tansey presented the data as the lead speaker at a press conference during the Society for Neuroscience 49th Annual Meeting in Chicago. “The new data strengthen our findings that a potential connection between diets rich…